The Lab. of Dr. Fonge develops theranostic agents against many different cancers. There is a current opening for a postdoctoral fellow trainee to develop novel theranostic radiopharmaceuticals. The ideal candidate would be proficient in developing novel techniques for bioconjugation of different radionuclides to peptides and antibodies, develop animal models of cancer (xenograft and PDX models) and microPET/SPECT/OI/CT imaging techniques. Experience working with radiometals is required.
Qualifications: Minimum qualifications include
- Ph.D with an impressive publication record, preferably within the last two years in one of the following areas: pharmaceutical sciences/pharmacy, pharmacology, radiopharmaceutical chemistry, nuclear medicine or chemistry.
Conditions: The position will be initially for two years with the possibility of an extension.The suggested salary is $40,000 – 45,000 CDN. The position is eligible for full benefit (CPP, health/dental and EI) package. Candidates will be required to present their research at local and international conferences in molecular imaging/oncology/pharmaceuticals sciences for which full financial support is available.
How to Apply: Review of applications will begin immediately until the position is filled. Please send a Cover Letter detailing your background and qualifications and how they match the position. Include full Curriculum Vitae (CV) detailing your education, awards, list of publications, abstracts presented at conferences, and research experience to the email address below. Attach a PDF file of at least two publications relevant to molecular imaging/radiopharmaceutical sciences and drug development, and arrange for two confidential reference letters (at least one of which must be from a current supervisor/former PhD supervisor) to be sent directly (via email) to the address below: